Cargando…
Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930003/ https://www.ncbi.nlm.nih.gov/pubmed/36792643 http://dx.doi.org/10.1038/s41598-023-29766-8 |
_version_ | 1784888962055143424 |
---|---|
author | Pirolli, Davide Righino, Benedetta Camponeschi, Chiara Ria, Francesco Di Sante, Gabriele De Rosa, Maria Cristina |
author_facet | Pirolli, Davide Righino, Benedetta Camponeschi, Chiara Ria, Francesco Di Sante, Gabriele De Rosa, Maria Cristina |
author_sort | Pirolli, Davide |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9930003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99300032023-02-15 Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface Pirolli, Davide Righino, Benedetta Camponeschi, Chiara Ria, Francesco Di Sante, Gabriele De Rosa, Maria Cristina Sci Rep Publisher Correction Nature Publishing Group UK 2023-02-15 /pmc/articles/PMC9930003/ /pubmed/36792643 http://dx.doi.org/10.1038/s41598-023-29766-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Publisher Correction Pirolli, Davide Righino, Benedetta Camponeschi, Chiara Ria, Francesco Di Sante, Gabriele De Rosa, Maria Cristina Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface |
title | Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface |
title_full | Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface |
title_fullStr | Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface |
title_full_unstemmed | Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface |
title_short | Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface |
title_sort | publisher correction: virtual screening and molecular dynamics simulations provide insight into repurposing drugs against sars-cov-2 variants spike protein/ace2 interface |
topic | Publisher Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930003/ https://www.ncbi.nlm.nih.gov/pubmed/36792643 http://dx.doi.org/10.1038/s41598-023-29766-8 |
work_keys_str_mv | AT pirollidavide publishercorrectionvirtualscreeningandmoleculardynamicssimulationsprovideinsightintorepurposingdrugsagainstsarscov2variantsspikeproteinace2interface AT righinobenedetta publishercorrectionvirtualscreeningandmoleculardynamicssimulationsprovideinsightintorepurposingdrugsagainstsarscov2variantsspikeproteinace2interface AT camponeschichiara publishercorrectionvirtualscreeningandmoleculardynamicssimulationsprovideinsightintorepurposingdrugsagainstsarscov2variantsspikeproteinace2interface AT riafrancesco publishercorrectionvirtualscreeningandmoleculardynamicssimulationsprovideinsightintorepurposingdrugsagainstsarscov2variantsspikeproteinace2interface AT disantegabriele publishercorrectionvirtualscreeningandmoleculardynamicssimulationsprovideinsightintorepurposingdrugsagainstsarscov2variantsspikeproteinace2interface AT derosamariacristina publishercorrectionvirtualscreeningandmoleculardynamicssimulationsprovideinsightintorepurposingdrugsagainstsarscov2variantsspikeproteinace2interface |